EliseAI vs Hyro (2026)
If your failure mode is choosing on a containment headline without asking whether the agent completes the task or merely routes it, this pair separates enterprise depth from multi channel breadth. Hyro is the enterprise build: the clearest architecture in the lane, a hybrid of large language models, a proprietary conversational engine, small healthcare tuned models, and knowledge graphs, with direct API into Epic and CRMs so it books and refills rather than answers, deployed across 45 to 50 health systems with an investing client. EliseAI is the broader channel play, handling a reported 95 percent of inquiries across voice, text, email, and chat with more than 50 languages, and publishing SOC 2 Type 2. Hyro if you are a large system that wants a controllable, transaction completing agent. EliseAI if you want wide channel coverage across the front office.
- Multi channel by design: one agent across voice, text, email, and chat with more than 50 languages, a reported 95 percent inquiry containment, and booking directly into the EHR.
- A stated SOC 2 Type 2 and HIPAA posture published on the product pages, which is a cleaner certification claim than Hyro's records carry here.
- Positioned for healthcare operations broadly rather than only large enterprise systems, if channel breadth matters more than deep enterprise integration.
- The clearest architecture in the index among voice vendors: a documented hybrid of LLMs, a proprietary conversational engine, small healthcare tuned models, and knowledge graphs, so a buyer can interrogate how the agent is constrained.
- Completes transactions through direct API into Epic and CRMs, booking and refilling rather than routing, which separates it from IVR replacement, backed by 45 to 50 health systems and an investing client.
- Independently corroborated enterprise adoption and third party recognition, including Fierce Healthcare's 2026 Fierce 15, a stronger evidence position than partner reported containment alone.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. EliseAI and Hyro are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | EliseAI | Hyro |
|---|---|---|
| Primary category | Patient Voice Agents | Patient Voice Agents |
| Founded | Not recorded | 2018 |
| Headquarters | New York, New York | New York, New York |
| Website | eliseai.com | hyro.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards EliseAI its top capability grade on AI Centrality. Set against Hyro, EliseAI grades higher on Security Certifications and Trust Center. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Hyro its top capability grade on AI Centrality, Model and Technology Transparency and EHR and Interoperability Depth. Set against EliseAI, Hyro grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose EliseAI or Hyro?
On the axes where the AI Health Index separates them, EliseAI grades higher on Security Certifications and Trust Center, and Hyro grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Hyro leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do EliseAI and Hyro differ most?
The widest separation the AI Health Index records between EliseAI and Hyro is on Model and Technology Transparency, where EliseAI grades C and Hyro grades A. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do EliseAI and Hyro grade the same?
The AI Health Index grades EliseAI and Hyro the same on several axes, including AI Centrality, Autonomy and Oversight Model and FDA and Regulatory Status. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have EliseAI and Hyro not disclosed?
At the last review, at least one of EliseAI and Hyro published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
Both are graded on vendor reported operational metrics without independent validation, and containment definitions vary widely across this category, so EliseAI's 95 percent and Hyro's up to 85 percent are not directly comparable without knowing each vendor's definition of a handled or routine interaction. Neither publishes escalation trigger criteria, the boundary that matters for refill requests.
Neither publishes pricing; Hyro is positioned as a premium tier for large systems, with smaller practices typically served by more general purpose alternatives, which may include EliseAI. EliseAI carries a graded SOC 2 Type 2 and HIPAA posture in this index while Hyro's record does not, so confirm Hyro's attestations directly. Voice accuracy can vary across accent and dialect, unquantified by either.